Promoters' Encumbrance Released: Docon Technologies Releases Pledge on 1.75 Crore Shares of Thyrocare Technologies Limited
Docon Technologies Private Limited, a promoter of Thyrocare Technologies Limited, has announced the release of a pledge concerning 1,75,00,000 equity shares of the company. This transaction occurred on August 11, 2026, involving the Debenture Trustee, Catalyst Trusteeship Limited.The pledge was created against Docon's substantial stake in Thyrocare Technologies Limited. As per disclosures made by Docon Technologies Private Limited, the company holds a total of 9,69,69,696 equity shares in Thyrocare, representing 60.92% of the equity share capital as of August 11, 2026.The release of the pledge pertains to a...